FdaApplication
ANDA 216272
Identifiers
- fda_app_no: ANDA216272
Properties
| Property | Value |
|---|---|
| applicant_name | NEPHRON PHARMACEUTICALS CORPORATION |
| application_type | ANDA |
| approval_date | 2026-06-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | EQ 1MG BASE/ML | INJECTABLE;INJECTION |
1 product